Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
12.62
-0.19 (-1.48%)
Nov 5, 2024, 1:16 PM EST - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $763.25 million as of November 5, 2024. Its market cap has increased by 616.67% in one year.
Market Cap
763.25M
Enterprise Value
499.16M
1-Year Change
616.67%
Ranking
Category
Stock Price
$12.62
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $763.25M, an increase of 585.20%. That is a compound annual growth rate of 60.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 769.30M | 68.26% |
| Dec 29, 2023 | 457.20M | 1,605.97% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.80M | 53.73% |
| Dec 31, 2020 | 102.00M | -8.43% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacira BioSciences | 764.32M |
| Arbutus Biopharma | 747.58M |
| Oculis Holding AG | 746.41M |
| Standard BioTools | 738.60M |
| Stoke Therapeutics | 677.05M |
| Tourmaline Bio | 674.37M |
| Humacyte | 673.93M |
| Cytek Biosciences | 671.99M |